Back to Results
First PageMeta Content
Boehringer Ingelheim / Pharmacy / Respimat / Dabigatran / Pharmaceutical industry / Tiotropium bromide / Chronic / Chemistry / Organic chemistry / Medicine


KEY ASPECTS 2014  Andreas Barner, Wolfgang Baiker, Allan Hillgrove, Joachim Hasenmaier, Hubertus von Baumbach (from left to right), the Board of Managing Directors KEY ASPECTS 2014
Add to Reading List

Document Date: 2015-04-16 05:31:57


Open Document

File Size: 115,45 KB

Share Result on Facebook
UPDATE